Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5278]

Three-drug combination helps curb the growth of deadly type of skin cancer

Three-drug combination helps curb the growth of deadly type of skin cancer

ASCO 2019: A tool to predict response to chemotherapy before bladder cancer surgery

ASCO 2019: A tool to predict response to chemotherapy before bladder cancer surgery

ASCO 2019: NCI-MATCH trial finds the combination of dabrafenib and trametinib effective

ASCO 2019: NCI-MATCH trial finds the combination of dabrafenib and trametinib effective

Immune cells determine how fast certain tumours grow

Immune cells determine how fast certain tumours grow

ASCO 2019: New TAILORx data guides adjuvant therapy in younger breast cancer patients

ASCO 2019: New TAILORx data guides adjuvant therapy in younger breast cancer patients

ASCO 2019: Cleveland researchers test novel gene therapy for glioblastoma

ASCO 2019: Cleveland researchers test novel gene therapy for glioblastoma

ASCO 2019: International clinical trial of new drug for men with advanced prostate cancer yields strong result

ASCO 2019: International clinical trial of new drug for men with advanced prostate cancer yields strong result

ASCO 2019: Novel targeted-antibody treatment produced responses in nearly half of patients with advanced urothelial cancer

ASCO 2019: Novel targeted-antibody treatment produced responses in nearly half of patients with advanced...

ASCO 2019: Maintenance therapy with PARP inhibitor olaparib delays progression of BRCA-related pancreatic cancer

ASCO 2019: Maintenance therapy with PARP inhibitor olaparib delays progression of BRCA-related pancreatic cancer

ASCO 2019: Combination checkpoint blockade effective in pre-surgical setting for early-stage lung cancers

ASCO 2019: Combination checkpoint blockade effective in pre-surgical setting for early-stage lung cancers

More from ecancer